Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

6.68
Delayed Data
As of Oct 17
 +0.01 / +0.15%
Today’s Change
4.11
Today|||52-Week Range
8.38
+13.99%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close6.67
Today’s open6.69
Day’s range6.67 - 6.98
Volume1,234,572
Average volume (3 months)1,358,429
Market cap$793.3M
Dividend yield--
Data as of 10/17/2017

Growth & Valuation

Earnings growth (last year)-27.73%
Earnings growth (this year)+21.29%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+133.79%
P/E ratioNM
Price/Sales19.39
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+0.22+1.23%
TGTXTG Therapeutics Inc-0.85-9.16%
BYSIBeyondspring Inc-0.77-2.10%
EGRXEagle Pharmaceutical...-0.89-1.76%
Data as of 10/17/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$32.0M
Annual profit (last year)-$161.1M
Net profit margin-503.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts